Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-21 @ 9:48 PM
Study NCT ID:
NCT05979857
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Salarius Pharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-08-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-31
First Submit QC Date:
None
Study First Post Date:
2023-08-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-20
Last Update Post Date:
2023-11-22
Last Update Post Date Type:
ACTUAL